SCHEMBL7744753

SCHEMBL7744753

O=C(Nc1cnco1)c1ccccc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.60
RAB9A P51151 2/20 0.60
KDM4E B2RXH2 1/20 0.60
ALDH1A1 P00352 1/20 0.60
LMNA P02545 1/20 0.60
PKM P14618 1/20 0.60
BCAT2 O15382 1/20 0.57
NAMPT P43490 2/20 0.50
IMPDH2 P12268 1/20 0.50
JAK2 O60674 1/20 0.50
TYK2 P29597 1/20 0.50
KMT2A Q03164 3/20 0.47
MEN1 O00255 2/20 0.47
KDM4D Q6B0I6 1/20 0.46
KDM4C Q9H3R0 1/20 0.46
KDR P35968 1/20 0.46
HTT P42858 1/20 0.46
MDM4 O15151 1/20 0.46
TP53 P04637 1/20 0.46
KCNK3 O14649 3/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3649700 0.82 NPC1 (0.46) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL18920602 0.73 SMN1; SMN2 (0.72) NPC1RAB9AKDM4EALDH1A1PKM
SCHEMBL4243217 0.73 BCAT2 (1.00) NPC1RAB9AKDM4ELMNABCAT2
SCHEMBL14759559 0.69 KMT2A (0.48) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL17079639 0.69 CSNK2A2 (0.53) NPC1RAB9AKDM4EALDH1A1LMNA
SCHEMBL29220747 0.68 HCAR3 (0.71) NPC1RAB9AKDM4EBCAT2KMT2A
SCHEMBL3299661 0.67 ADORA1 (0.70) NPC1RAB9ALMNABCAT2JAK2
SCHEMBL11831465 0.67 MEN1 (0.64) NPC1RAB9AKDM4EBCAT2JAK2
SCHEMBL164882 0.67 JAK2 (1.00) NPC1RAB9AKDM4EALDH1A1PKM
SCHEMBL27822956 0.67 MEN1 (0.58) NPC1RAB9AALDH1A1PKMKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP claimed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP claimed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO claimed
WO-2014079850-A1 SUBSTITUTED HETEROCYCLIC DERIVATIVES F. HOFFMANN-LA ROCHE AG (CH) 2014-05-30 WO disclosed
EP-1097147-A4 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO INC (US) 2001-11-21 EP disclosed
EP-1097147-A1 NOVEL ANGIOGENESIS INHIBITORS Merck & Co., Inc. (US) 2001-05-09 EP disclosed
WO-2000002871-A1 NOVEL ANGIOGENESIS INHIBITORS MERCK & CO., INC. (US) 2000-01-20 WO disclosed